AMGN:BMV
Amgen Inc
MX$7,500.01
0.00%
(0.00) 1D
Oct 1, 1:43:26 PM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN...
Mkt. cap
224.29B
Avg. vol.
127.00
Volume
470.00
52-wk high
MX$7,580.50
52-wk low
MX$5,300.00
Shares outstanding
637.22M
No. of employees
32K
Mkt. cap
224.29B
Avg. vol.
127.00
Volume
470.00
52-wk high
MX$7,580.50
52-wk low
MX$5,300.00
Shares outstanding
637.22M
No. of employees
32K
News stories
From web sources and news partners
AD HOC NEWS
·
10 hours ago
Amgen stock trades at USD 414.87 versus USD 407.44 in U.S. trading
MarketBeat
·
19 hours ago
Amgen Inc. $AMGN Stock Sold by Castle Rock Wealth Management LLC
MarketWatch
·
22 hours ago
Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains
TipRanks
·
2 days ago
Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees31.5K
Founded1980
HeadquartersThousand Oaks, California, United States
SectorBiotechnology
Websiteamgen.com